Table 1.
The clinical, histological, and molecular characteristics of all 26 uveal melanoma (UM) patients.
| Patients Characteristics | Low Risk Group | Intermediate Risk Group | High Risk Group |
|---|---|---|---|
| (n = 7) | (n = 12) | (n = 7) | |
| Age | |||
| Mean ± SD | 58 ± 9 | 50 ± 15 | 69 ± 14 |
| Gender, N (%) | |||
| Male | 5 (71) | 5 (42) | 1 (14) |
| Female | 2 (29) | 7 (58) | 6 (86) |
| Disease free survival | |||
| Mean ± SD | 145.1 ± 45.1 | 103.3 ± 50.6 | 28.2 ± 9.26 |
| Mutation status, N (%) | |||
| GNAQ | 4 (57) | 7 (58) | 4 (57) |
| GAN11 | 3 (43) | 5 (42) | 3 (43) |
| EIF1AX | 7 (100) | 0 (0) | 0 (0) |
| SF3B1 | 0 (0) | 12 (100) | 0 (0) |
| BAP1 | 0 (0) | 0 (0) | 7 (100) |
| Monosomy 3, N (%) | |||
| Present | 0 (0) | 0 (0) | 7 (100) |
| Absent | 7 (100) | 11 (92) | 0 (0) |
| NE | 0(0) | 1 (8) | 0 (0) |
| BAP1 IHC, N (%) | |||
| Positive | 7 (100) | 12 (100) | 0 (0) |
| Negative | 0 (0) | 0 (0) | 7 (100) |
| Metastasis | |||
| Present | 0 (0) | 9 (75) | 7 (100) |
| Absent | 7 (0) | 3 (25) | 0 (0) |